<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 63-year-old male was admitted to our department in 2001 because of <z:hpo ids='HP_0001890'>autoimmune haemolytic anaemia</z:hpo> and <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Bone marrow examination revealed an <z:hpo ids='HP_0012132'>erythroid hyperplasia</z:hpo> and a <z:mpath ids='MPATH_458'>normal</z:mpath> chromosome analysis </plain></SENT>
<SENT sid="2" pm="."><plain>Splenectomy was performed in 2002, resulting in severe transfusion-dependent <z:hpo ids='HP_0001903'>anaemia</z:hpo> with a need for two blood transfusions each week </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment with <z:chebi fb="2" ids="8378">prednisolone</z:chebi>, erythropoietin and <z:chebi fb="2" ids="4315">danocrine</z:chebi> was without effect </plain></SENT>
<SENT sid="4" pm="."><plain>A new bone marrow examination then showed <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Treatment with thalidomide, 50-150 mg/d, and <z:chebi fb="2" ids="8378">prednisolone</z:chebi>, 25 mg/d, resulted in an increase in <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> to 8.9 mmol/l during the following months </plain></SENT>
<SENT sid="6" pm="."><plain>The use of immunomodulatory and anti-angiogenetic agents in refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> needs more study </plain></SENT>
</text></document>